Elevance Health, Inc.
Institutional investors holding ELV
| Investor | Weight | Quarter |
|---|---|---|
| Glenn Greenberg | 8.13% | 2026Q1 |
| Viking Global Investors | 2.57% | 2023Q2 |
| Harry Burn | 2.02% | 2024Q3 |
| Bill Nygren | 2.00% | 2026Q1 |
| First Eagle Investment Management | 1.60% | 2026Q1 |
| Yacktman Asset Management | 1.31% | 2026Q1 |
| Chris Hohn | 0.93% | 2020Q1 |
| Richard Pzena | 0.21% | 2026Q1 |
| Tweedy Browne Co. | 0.11% | 2026Q1 |
| Christopher Davis | 0.02% | 2015Q1 |
| Bill & Melinda Gates Foundation | 0.01% | 2023Q3 |
| Kenneth Fisher | 0.00% | 2026Q1 |
| Dodge & Cox | 0.00% | 2026Q1 |
Congressional data coming soon
13
Total trades
$1.1M
Volume
10
Buys
1
Sells
Last trade: May 19, 2026
| Date | Insider | Type | Value |
|---|---|---|---|
| May 19, 2026 | Ronald W Penczek | Sell | $617K |
| May 19, 2026 | Ronald W Penczek | Option | $177K |
Congressional trade data is being sourced and will appear here shortly.
| May 19, 2026 |
| Ronald W Penczek |
| Option |
| $273K |
| May 13, 2026 | Steven H Collis | Buy | – |
| May 13, 2026 | Susan D. Devore | Buy | – |
| May 13, 2026 | Robert L Dixon JR | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |
| May 13, 2026 | Ronald W Penczek | Buy | – |